AI Summary

Researchers found that a specific RNA molecule helps triple‑negative breast cancer cells resist chemotherapy. The study focused on stage I–III TNBC, where surgery and chemotherapy are standard, and noted that only a minority of patients respond to PARP‑inhibitor targeted therapy due to BRCA mutations.

AI summaries can be wrong sometimes—always verify important details using the source article.